Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ · Healthcare
Oramed Pharmaceuticals Inc. Long Term Debt 2016–2025
Oramed Pharmaceuticals Inc. annual/quarterly long term debt history from 2018 to 2022. Long term debt refers to financial obligations that are due more than one year in the future.
- Oramed Pharmaceuticals Inc. long term debt for the quarter ending December 31, 2022 were 25,000.
- Oramed Pharmaceuticals Inc. long term debt for 2022 were 25,000, a 99.80% decrease from 2021.
- Oramed Pharmaceuticals Inc. long term debt for 2021 were 12.5M, a 29.87% increase from 2019.
- Oramed Pharmaceuticals Inc. long term debt for 2019 were 9.7M, a 15.19% decrease from 2018.
- Oramed Pharmaceuticals Inc. long term debt for 2018 were 11.4M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Oramed Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2022 | $0 |
| 2021 | $13 |
| 2019 | $10 |
| 2018 | $11 |
| Oramed Pharmaceuticals Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2022-12-31 | $0 |
| 2021-08-31 | $13 |
| 2019-08-31 | $10 |
| 2018-08-31 | $11 |
Oramed Pharmaceuticals Inc. Long Term Debt — FAQ
Oramed Pharmaceuticals Inc. (ORMP) long term debt over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ORMP's long term debt history?
The chart and table above show Oramed Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.